Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Gemeinschaftspraxis für Hämatologie und Onkologie

Research site

Germany Steinfurter Strasse 60 b, 48149 Munster, Germany

  • Non-small cell lung cancer · Non-small cell lung cancer stage III · Non-small cell lung cancer stage IIIA
  • Adult patients

About Specializations

Gemeinschaftspraxis für Hämatologie und Onkologie in Munster, Germany specialises in clinical trials of conditions such as Non-small cell lung cancer, Non-small cell lung cancer stage III, Non-small cell lung cancer stage IIIA, Non-small cell lung cancer stage IIIB, and other specialisations. This site conducts important research.

Main research areas of the site

Neoplasms

The Gemeinschaftspraxis für Hämatologie und Onkologie is conducting focused research on Non‑Small Cell Lung Cancer, evaluating new immunotherapy approaches and their impact on disease‑free survival.

  • Immunotherapy with checkpoint inhibitors
  • Combination of radiotherapy and immunotherapy
  • Safety and tolerability assessments

Based in Munster, Germany, the site currently runs two investigator‑led trials with a team of two investigators, aiming to improve treatment outcomes for lung cancer patients.

Respiratory Tract Diseases

Research at this practice also targets unresectable stage III NSCLC, exploring optimized radiotherapy schedules and the addition of durvalumab to enhance therapeutic response in patients unable to receive chemotherapy.

  • Optimized radiotherapy fractionation
  • Elderly and frail patient cohorts
  • Biomarker‑driven efficacy studies

The clinical program reflects a commitment to advancing care for respiratory malignancies, with two active studies and a dedicated research team.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Steinfurter Strasse 60 b48149 MunsterGermany
Open in maps ↗
Recruiting now
no trials
Conditions studied
4

More sites in MunsterGermany

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Non-small cell lung cancer stage III+2

Not recruiting

Study on Thoracic Radiotherapy and Durvalumab for Elderly or Frail Stage III Non-Small Cell Lung Cancer Patients Unable to Undergo Chemotherapy

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH

Non-small cell lung cancer

Not recruiting

Study on Atezolizumab for Patients with Non-Small Cell Lung Cancer After Chemotherapy

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:F. Hoffmann-La Roche AG
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.